Who would have predicted that on a day when Medtronic reports earnings it would be a secondary story in our wacky world. Before we get into the bigger news, which will come in a sperate post let’s take a look at the Medtronic earnings which for their diabetes unit continue to struggle. According to one of the slides used during the call;
“U.S. Revenue: Declined high-teens, primarily due to new patient starts delayed by closing of physician offices, and competitive challenges”
The earnings release states;
“Diabetes Group fourth quarter revenue of $570 million decreased 9 percent as . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.